Accord Healthcare Polska Sp. z o.o. Warehouse Importer (Responsible for batch release)

Ukraine

All drugs from this manufacturer

  • BORTIB®

    The drug is used for the treatment of adult patients with multiple myeloma (either as monotherapy or in combination with other agents), as well as for the treatment of mantle cell lymphoma.

    Dosage form: solution for injection

    Active substance Dosage
    bortezomib 2.5 mg/ml

    ATC: L01XG01

  • CABAZITAXEL ACCORD

    The drug is indicated for the treatment of adult patients with hormone-refractory metastatic prostate cancer who have previously received treatment with a docetaxel-based regimen.

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    cabazitaxel 20 mg/ml

    ATC: L01CD04